Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Minocycline; Tigecycline

Criteria

Inclusion Criteria:

• All patients from the study center who received or will receive at least one dose of Tygacil according to the approved product indication.

Exclusion Criteria:

• Previously discontinued Tygacil therapy due to significant safety concern.